Translational Development Acquisition reported net income of $0.95M for the quarter ended Jun 2026. This income statement covers 9 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||
| Selling, General & AdministrativeSG&A | 0.06M | 0.13M | 0.35M | 0.22M | 0.21M | 0.16M | 0.28M | 0.66M | |
| Other Operating ExpensesOther Opex | 0.49M | ||||||||
| Operating ExpensesOpex | 0.49M | 0.06M | 0.13M | 0.35M | 0.22M | 0.21M | 0.16M | 0.28M | 0.66M |
| Operating IncomeOp. Inc | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| EBIT | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| Non-operating items | |||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.13M | -0.04M | |||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.13M | 1.83M | 1.84M | 1.87M | 1.63M | 1.61M | 1.64M | ||
| Non Operating IncomeNon Op. Inc. | 0.13M | 1.83M | 1.84M | 1.87M | 1.76M | 1.61M | 1.61M | ||
| Net income details | |||||||||
| EBT | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| Profit After TaxPAT | -0.06M | -0.01M | 1.48M | 1.62M | 1.66M | 1.60M | 1.33M | 0.95M | |
| Income from Continuing OperationsIncome (Continuing) | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| Consolidated Net IncomeConsol Net Inc. | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| Income towards Parent CompanyParent Net Inc | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M | |
| Net Income towards Common StockholdersNet Income | -0.06M | -0.00M | 1.17M | 1.28M | 1.31M | 1.26M | 1.05M | 0.74M | |
| Additional items | |||||||||
| EPS (Basic) | -0.02 | 0.00 | 0.05 | 0.06 | 0.06 | 0.07 | 0.05 | 0.03 | |
| EPS (Diluted) | -0.02 | 0.00 | 0.05 | 0.06 | 0.06 | 0.07 | 0.05 | 0.03 | |
| Shares Outstanding | 8.10M | 4.05M | 4.06M | 21.91M | 21.91M | 21.91M | 17.25M | 21.91M | 21.51M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 8.10M | 4.05M | 9.98M | 21.91M | 21.91M | 21.91M | 17.25M | 21.91M | 21.51M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 8.10M | 25.97M | 25.97M | 26.57M | 26.57M | 26.57M | 26.57M | 26.57M | 28.62M |
| EBITDA | -0.06M | -0.13M | -0.35M | -0.22M | -0.21M | -0.16M | -0.28M | -0.66M |